← Back to Clinical Trials
Recruiting NCT04262492
International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants
Trial Parameters
Condition Antiphospholipid Syndrome
Sponsor Stéphane Zuily
Study Type OBSERVATIONAL
Phase N/A
Enrollment 500
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2020-10-21
Completion 2030-04
All Conditions
Interventions
Rivaroxaban
Brief Summary
This registry, currently being established will ensure consistency of data collection and provide safety information in non high-risk APS patients currently on DOACs.
Eligibility Criteria
Inclusion Criteria: * Patient receiving a comprehensive information about the study, and not opposed to participate * Age ≥ 18 yo * Classification of definite APS according to revised Sapporo-Sydney criteria * Direct oral anticoagulant treatment prescribed during at least 6 months or with the possibility of follow-up of at least 6 months Exclusion Criteria: * Incomplete revised Sapporo-Sydney criteria * No data regarding the recurrent thrombosis * Pregnant woman * Age \< 18 yo